Abstract | PURPOSE: METHODS: Medical records of patients who received either shallow or deep CO2 laser vaporization with biopsy-proven CIN2 during March 2007 to April 2011 were reviewed retrospectively. After laser vaporization, liquid-based cytology and human papilloma virus (HPV) DNA testing were checked in every follow-up visit. Treatment failure was defined when the follow-up biopsy was more than CIN2, needing secondary surgical treatment. RESULTS: During that period, 141 patients with CIN2 underwent CO2 laser vaporization. After laser ablation, 14 of 141 women needed the secondary treatment, a success rate of laser vaporization of 90.1 %. In multivariate analysis, the previous loop electrosurgical excision procedure (LEEP) history (adjusted OR = 13.649; P value = 0.025) and the ablation depth (adjusted OR = 11.279; P value = 0.006) were independent factors associated with treatment failure. CONCLUSION: Both ablation depth and previous LEEP history were the important factors increasing the risk for the treatment failure of CO2 laser vaporization in CIN2.
|
Authors | Bo Sung Yoon, Seok Ju Seong, Taejong Song, Mi-La Kim, Mi Kyoung Kim |
Journal | Archives of gynecology and obstetrics
(Arch Gynecol Obstet)
Vol. 290
Issue 1
Pg. 115-9
(Jul 2014)
ISSN: 1432-0711 [Electronic] Germany |
PMID | 24458427
(Publication Type: Evaluation Study, Journal Article)
|
Topics |
- Adult
- Aged
- Biopsy
- Colposcopes
- Female
- Human Papillomavirus DNA Tests
- Humans
- Laser Therapy
(adverse effects, methods)
- Lasers, Gas
(therapeutic use)
- Middle Aged
- Multivariate Analysis
- Retrospective Studies
- Risk Factors
- Treatment Failure
- Uterine Cervical Neoplasms
(pathology, surgery)
- Uterine Cervical Dysplasia
(pathology, surgery)
|